from Airway Smooth Muscle Cells in Endothelial Growth Factor 165a Secretion Responsible for Increased Vascular Abnormal Histone Methylation Is
暂无分享,去创建一个
[1] J. Ko,et al. Epigenetic mechanisms for silencing glutathione S‐transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer , 2011, Cancer.
[2] W. Coward,et al. Transcriptional regulation of inflammatory genes associated with severe asthma. , 2011, Current pharmaceutical design.
[3] Mauro Giacca,et al. Non-redundant functions of the protein isoforms arising from alternative splicing of the VEGF-A pre-mRNA , 2010, Transcription.
[4] R. Schüle,et al. Epigenetic regulation of cancer growth by histone demethylases , 2010, International journal of cancer.
[5] Prerna Kumar,et al. Interactive Roles of Ets-1, Sp1, and Acetylated Histones in the Retinoic Acid-dependent Activation of Guanylyl Cyclase/Atrial Natriuretic Peptide Receptor-A Gene Transcription* , 2010, The Journal of Biological Chemistry.
[6] B. Hammock,et al. DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism. , 2010, Biochimica et biophysica acta.
[7] Yi Zhang,et al. Active DNA demethylation: many roads lead to Rome , 2010, Nature Reviews Molecular Cell Biology.
[8] M. Masuda,et al. Cardiovascular , Pulmonary and Renal Pathology Early Growth Response-1 Induces and Enhances Vascular Endothelial Growth Factor-A Expression in Lung Cancer Cells , 2010 .
[9] Philipp Bucher,et al. KRAB–Zinc Finger Proteins and KAP1 Can Mediate Long-Range Transcriptional Repression through Heterochromatin Spreading , 2010, PLoS genetics.
[10] C. Brightling,et al. Airway smooth muscle proliferation and survival is not modulated by mast cells , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[11] S. Chakrabarti,et al. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. , 2010, American journal of physiology. Endocrinology and metabolism.
[12] M. Mancarelli,et al. The tumor suppressor gene KCTD11REN is regulated by Sp1 and methylation and its expression is reduced in tumors , 2010, Molecular Cancer.
[13] Mingyao Liu,et al. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. , 2009, Cancer research.
[14] H. Riethman,et al. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. , 2009, Molecular cell.
[15] D. Bates,et al. VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo , 2009, British Journal of Cancer.
[16] H. Cedar,et al. Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.
[17] Levon M. Khachigian,et al. Sp1 Phosphorylation and Its Regulation of Gene Transcription , 2009, Molecular and Cellular Biology.
[18] X. Fang,et al. Sp-1 and c-Myc Mediate Lysophosphatidic Acid–Induced Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Cells via a Hypoxia-Inducible Factor-1–Independent Mechanism , 2009, Clinical Cancer Research.
[19] A. Knox,et al. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta). , 2008, The Journal of biological chemistry.
[20] Jennifer A. Mitchell,et al. The Air Noncoding RNA Epigenetically Silences Transcription by Targeting G9a to Chromatin , 2008, Science.
[21] S. Prasanna Kumar,et al. Butyrate-induced phosphatase regulates VEGF and angiogenesis via Sp1. , 2008, Archives of biochemistry and biophysics.
[22] B. O'connor,et al. Induction of angiogenesis by airway smooth muscle from patients with asthma. , 2008, American journal of respiratory and critical care medicine.
[23] Lena Claesson-Welsh,et al. Claesson-Welsh L: Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity , 2022 .
[24] T. Kimura,et al. Zinc-Induced Formation of a Coactivator Complex Containing the Zinc-Sensing Transcription Factor MTF-1, p300/CBP, and Sp1 , 2008, Molecular and Cellular Biology.
[25] M. Chopp,et al. Ectopic decorin expression up‐regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1α, and Stat3 , 2008, Journal of neurochemistry.
[26] L. Hurley,et al. The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex–interactive agents , 2008, Molecular Cancer Therapeutics.
[27] P. Jagodziński,et al. 5-Aza-2'-deoxycytidine increases the expression of anti-angiogenic vascular endothelial growth factor 189b variant in human lung microvascular endothelial cells. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[28] Y. Song,et al. Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Sedum sarmentosum extract. , 2008, Journal of ethnopharmacology.
[29] I. Pavord,et al. Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis. , 2007, The Journal of allergy and clinical immunology.
[30] L. Cuppini,et al. The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells , 2007, Leukemia.
[31] B. O'connor,et al. Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. , 2007, American journal of respiratory and critical care medicine.
[32] V. Douet,et al. DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. , 2007, Biochemical and biophysical research communications.
[33] H. Stunnenberg,et al. Identification of novel functional TBP‐binding sites and general factor repertoires , 2007, The EMBO journal.
[34] Young Kyoon Kim,et al. Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[35] C. Brightling,et al. Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. , 2006, American journal of respiratory and critical care medicine.
[36] B. Murphy,et al. Transcriptional Regulation of Uterine Vascular Endothelial Growth Factor during Early Gestation in a Carnivore Model, Mustela vison* , 2006, Journal of Biological Chemistry.
[37] Abby L. Mulkeen,et al. Post-transcriptional regulation of vascular endothelial growth factor: implications for tumor angiogenesis. , 2006, World journal of gastroenterology.
[38] E. Walters,et al. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. , 2006, American journal of respiratory and critical care medicine.
[39] R. Panettieri,et al. Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype. , 2006, American journal of respiratory cell and molecular biology.
[40] Salwa Bakr,et al. A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. , 2006, Chest.
[41] C. Seedhouse,et al. Vascular Endothelial Growth Factor Induction by Prostaglandin E2 in Human Airway Smooth Muscle Cells Is Mediated by E Prostanoid EP2/EP4 Receptors and SP-1 Transcription Factor Binding Sites* , 2005, Journal of Biological Chemistry.
[42] M. Abdelrahim,et al. Cyclooxygenase-2 Inhibitors Decrease Vascular Endothelial Growth Factor Expression in Colon Cancer Cells by Enhanced Degradation of Sp1 and Sp4 Proteins , 2005, Molecular Pharmacology.
[43] Jung Weon Lee,et al. The FASEB Journal express article 10.1096/fj.04-3099fje. Published online May 26, 2005. ©2005 FASEB , 2022 .
[44] J. Weis,et al. Interleukin‐6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1 , 2005, International journal of cancer.
[45] E. Wang,et al. TAF1 Histone Acetyltransferase Activity in Sp1 Activation of the Cyclin D1 Promoter , 2005, Molecular and Cellular Biology.
[46] Martha R. Stampfer,et al. Chromatin Inactivation Precedes De Novo DNA Methylation during the Progressive Epigenetic Silencing of the RASSF1A Promoter , 2005, Molecular and Cellular Biology.
[47] Hiroshi Tanaka,et al. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. , 2005, Chest.
[48] J. Pouysségur,et al. Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors. , 2005, Cardiovascular research.
[49] R. Day,et al. Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr‐1 , 2005, Journal of cellular biochemistry.
[50] P. Finn,et al. Epigenetic approaches to cancer therapy. , 2004, Biochemical Society transactions.
[51] Marina Ziche,et al. VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant , 2004, Cancer Research.
[52] M. Simon,et al. Regulation of Transcription and Translation by Hypoxia , 2004, Cancer biology & therapy.
[53] G. Wilson,et al. Ref‐1/Ape is critical for formation of the hypoxia‐inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[54] J. Yoshikawa,et al. Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. , 2004, American journal of respiratory and critical care medicine.
[55] E. Goncharova,et al. Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[56] K. Wright,et al. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing , 2004, Nature Immunology.
[57] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[58] K. Hirata,et al. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[59] K. Hirata,et al. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients , 2002, Thorax.
[60] D. Gillatt,et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. , 2002, Cancer research.
[61] D. McDonald,et al. Angiogenesis and remodeling of airway vasculature in chronic inflammation. , 2001, American journal of respiratory and critical care medicine.
[62] A. Knox,et al. Human airway smooth muscle cells secrete vascular endothelial growth factor: up‐regulation by bradykinin via a protein kinase C and prostanoid‐dependent mechanism , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[63] T. Jenuwein,et al. Structure-Function Analysis of SUV39H1 Reveals a Dominant Role in Heterochromatin Organization, Chromosome Segregation, and Mitotic Progression , 2000, Molecular and Cellular Biology.
[64] J Bousquet,et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.
[65] J. Wilson,et al. Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.
[66] C. Koller,et al. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. , 1991, The Journal of clinical investigation.
[67] J. Anderson,et al. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema , 1969, Thorax.